Trial Profile
A Randomized, Multicenter, Double-Masked, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Vancomycin Hydrochloride Ophthalmic Ointment 1.1% in Patients With Moderate to Severe Bacterial Conjunctivitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Vancomycin (Primary)
- Indications Bacterial infections; Conjunctivitis; Gram-positive infections
- Focus Therapeutic Use
- 12 Feb 2019 Status changed from recruiting to completed.
- 18 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
- 18 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Apr 2018.